Neutralizer Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 0.66 M
- Company Age 30 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -12.12%
- Ebitda -12.12%
- Net Worth -4.08%
- Total Assets -8.20%
About Neutralizer Pharmaceuticals
Neutralizer Pharmaceuticals Limited (NPL) is a Public Limited Indian Non-Government Company incorporated in India on 05 October 1994 and has a history of 30 years and four months. Its registered office is in Pune, Maharashtra, India.
The Corporate was formerly known as Vardhaman Drugs Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.66 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Shah, Avinash Wadgaonkar, and Ajay Jadhav serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239MH1994PLC071053
-
Company No.
071053
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
05 Oct 1994
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Neutralizer Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Shah
|
Director | 05-Oct-1994 | Current |
|
Avinash Wadgaonkar
|
Director | 29-May-2020 | Current |
|
Ajay Jadhav
|
Director | 29-May-2020 | Current |
Financial Performance of Neutralizer Pharmaceuticals.
Neutralizer Pharmaceuticals Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 12.12% decrease in profit. The company's net worth dipped by a decrease of 4.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neutralizer Pharmaceuticals?
In 2019, Neutralizer Pharmaceuticals had a promoter holding of 89.05% and a public holding of 10.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vardhaman Laboratories LimitedSunil Shah is a mutual person
-
Vardhaman Finance And Leasing LimitedSunil Shah is a mutual person
-
Chitte Hospital Llp
Avinash Wadgaonkar is a mutual person
-
Laakshith Bizcorp Solutions (Opc) Private Limited
Avinash Wadgaonkar is a mutual person
-
Anw Studios Private Limited
Avinash Wadgaonkar and Ajay Jadhav are mutual person
-
Dhannyasukh Micro Services Foundation
Ajay Jadhav is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neutralizer Pharmaceuticals?
Unlock and access historical data on people associated with Neutralizer Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neutralizer Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neutralizer Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
